ACE and infective endocarditis: Although our findings do not endorse a specific preoperative ACE inhibitor management strategy, they emphasize the importance of individualized patient care, particularly in high-risk cases (e.g., chronic renal impairment, atrial fibrillation, infective endocarditis, and severe heart failure), as recommended by international guidelines.